How does pulmonary arterial hypertension (PAH) cause chest pain during exercise?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Pulmonary arterial hypertension (PAH) causes chest pain during exercise primarily due to increased right ventricular workload and myocardial oxygen demand that cannot be met, as evidenced by the most recent study 1. When a person with PAH exercises, the already elevated pulmonary pressures rise even higher as cardiac output increases, forcing the right ventricle to work harder against this resistance. This creates a supply-demand mismatch where the right ventricle requires more oxygen but cannot receive adequate blood flow through the coronary arteries. The resulting ischemia triggers chest pain, often described as angina. Some key points to consider in the management of PAH-related chest pain include:

  • The importance of optimizing disease-targeted medical therapy, as suggested by 1
  • The potential benefits of pulmonary rehabilitation, including exercise endurance training, in improving mobility, social interaction, exercise tolerance, and quality of life, as noted in 1
  • The need for careful monitoring and management of PAH, including regular assessment of symptoms, heart rate, and oxygenation response, as recommended by 1 Additionally, the enlarged right ventricle may compress the left ventricle, reducing left heart filling and coronary perfusion. The high pressures in the pulmonary circulation can also cause pulmonary artery distension, which may directly stimulate pain receptors in the vessel walls. In severe cases, right ventricular strain may lead to tricuspid regurgitation and further compromise cardiac function during exertion. Patients with PAH-related chest pain should immediately reduce activity when symptoms occur and follow their prescribed PAH treatment regimen, which typically includes medications like endothelin receptor antagonists, phosphodiesterase-5 inhibitors, or prostacyclin analogs to reduce pulmonary vascular resistance, as suggested by 1.

From the Research

Pulmonary Arterial Hypertension and Chest Pain

Pulmonary arterial hypertension (PAH) is a progressive disorder characterized by hypertension in the pulmonary arteries, leading to symptoms such as shortness of breath, dizziness, leg edema, and chest pain 2. The exact mechanism of how PAH causes chest pain during exercise is not fully understood, but several studies provide insights into the condition.

Pathophysiology of PAH

PAH is characterized by a progressive increase of pulmonary vascular resistance (PVR), initially due to abnormal pulmonary vasoconstriction in response to endothelial injury 3. This increased resistance leads to right ventricular hypertrophy and eventual right heart failure. The endothelin pathway plays a crucial role in vasoconstriction and remodeling of the pulmonary microcirculation 3.

Exercise and PAH

Exercise training has been shown to improve physical fitness in patients with PAH, increasing 6-minute walk distance and peak oxygen uptake 2. However, exercise can also exacerbate symptoms, including chest pain. The increased demand on the right heart during exercise can lead to increased pulmonary artery pressure, which may cause chest pain.

Treatment of PAH

Several treatments are available for PAH, including endothelin receptor antagonists (ERAs), phosphodiesterase-5 (PDE-5) inhibitors, and prostacyclin analogs 4, 5. These treatments aim to reduce pulmonary vascular resistance and improve exercise capacity. Combination therapy with ERAs and PDE-5 inhibitors has been shown to be effective in improving 6-minute walk distance and reducing clinical worsening 6.

Key Findings

  • PAH is characterized by a progressive increase of pulmonary vascular resistance, leading to right ventricular hypertrophy and eventual right heart failure 3.
  • Exercise training can improve physical fitness in patients with PAH, but may also exacerbate symptoms, including chest pain 2.
  • Combination therapy with ERAs and PDE-5 inhibitors is effective in improving 6-minute walk distance and reducing clinical worsening 6.
  • The endothelin pathway plays a crucial role in vasoconstriction and remodeling of the pulmonary microcirculation 3.

Some key points to consider:

  • PAH is a complex condition, and the exact mechanism of how it causes chest pain during exercise is not fully understood.
  • Treatment of PAH should be individualized, taking into account the patient's specific needs and requirements 6.
  • Further research is needed to fully understand the relationship between PAH, exercise, and chest pain.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.